Solution structure of Rhodostomin G50L mutant
Design of Integrin AlphaVbeta3-Specific Disintegrin for Cancer Therapy
Disintegrin kistrin, Platelet aggregation activation inhibitor
DGSA-distance geometry simulated annealing
2 mM Rhodostomin G50L mutant-1, 90% H2O/10% D2O
2 mM Rhodostomin G50L mutant-2, 100% D2O
2 mM [U-99% 15N] Rhodostomin G50L mutant-3, 90% H2O/10% D2O
2 mM [U-99% 15N] Rhodostomin G50L mutant-4, 100% D2O